Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul G Argula

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Respiratory Disease|April 18, 2026
Beneath the surface: a narrative review of multidimensional burdens and pathways to patient-centered care in PAHDenise Gabrielle A Sese, Rahul G Argula
Therapeutics and Clinical Risk Management|December 20, 2019
Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)Rahul G Argula, Celine Ward, Carol Feghali-Bostwick
Journal of Intensive Care Medicine|June 12, 2013
Multiorgan system dysfunction in the chylomicronemia syndromeRahul G Argula, Charlie Strange, Milos N Budisavljevic
Chest|July 6, 2013
Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysemaRahul G Argula, Charlie Strange, Viswanathan Ramakrishnan, et al.
Clinical Cardiology|February 20, 2015
Role of a 12-lead electrocardiogram in the diagnosis of cardiac tamponade as diagnosed by transthoracic echocardiography in patients with malignant pericardial effusionRahul G Argula, Smita I Negi, Jose Banchs, et al.
Lung|May 6, 2020
Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysisNoah C Schoenberg, Rahul G Argula, Elizabeth S Klings, et al.
Journal of Scleroderma and Related Disorders|December 2, 2024
Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertensionSamuel H Friedman, Russell A Harley, Jacob Williams, et al.
Annals of the American Thoracic Society|January 23, 2016
A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in LymphangioleiomyomatosisRahul G Argula, Maria Kokosi, Pechin Lo, et al.
The European Respiratory Journal|April 20, 2023
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension studyAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
Annals of the American Thoracic Society|March 11, 2017
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial HypertensionRahul G Argula, Abhijit Karwa, Abigail Lauer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Respiratory Disease|April 18, 2026
Beneath the surface: a narrative review of multidimensional burdens and pathways to patient-centered care in PAHDenise Gabrielle A Sese, Rahul G Argula
Therapeutics and Clinical Risk Management|December 20, 2019
Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)Rahul G Argula, Celine Ward, Carol Feghali-Bostwick
Journal of Intensive Care Medicine|June 12, 2013
Multiorgan system dysfunction in the chylomicronemia syndromeRahul G Argula, Charlie Strange, Milos N Budisavljevic
Chest|July 6, 2013
Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysemaRahul G Argula, Charlie Strange, Viswanathan Ramakrishnan, et al.
Clinical Cardiology|February 20, 2015
Role of a 12-lead electrocardiogram in the diagnosis of cardiac tamponade as diagnosed by transthoracic echocardiography in patients with malignant pericardial effusionRahul G Argula, Smita I Negi, Jose Banchs, et al.
Lung|May 6, 2020
Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysisNoah C Schoenberg, Rahul G Argula, Elizabeth S Klings, et al.
Journal of Scleroderma and Related Disorders|December 2, 2024
Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertensionSamuel H Friedman, Russell A Harley, Jacob Williams, et al.
Annals of the American Thoracic Society|January 23, 2016
A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in LymphangioleiomyomatosisRahul G Argula, Maria Kokosi, Pechin Lo, et al.
The European Respiratory Journal|April 20, 2023
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension studyAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
Annals of the American Thoracic Society|March 11, 2017
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial HypertensionRahul G Argula, Abhijit Karwa, Abigail Lauer, et al.
Pageof 2